After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful ...

Despite high demand for an option like Journavx, doctors fear the drug’s price could be a major hangup for insurers, ...

The offerings reflect an increase in IPO activity that could continue, as four other biotechs recently outlined plans to go ...

Democrats sought answers from RFK Jr. on how the Trump administration would handle Medicare price negotiations after a short ...

Robert F. Kennedy Jr., nominated to be health secretary, seemed unfamiliar with the particulars of the massive insurance ...

The approval adds a new indication for GLP-1 drugs and gives Novo an advantage over Lilly’s rival diabetes drug Mounjaro, ...

States and providers regained access to a key healthcare payments portal late Tuesday amid pushback over the Trump ...

The FDA clearance aids AstraZeneca and Daiichi Sankyo’s plan to position ADCs like Enhertu ahead of chemotherapy in a variety ...

The startup says its specially constructed RNAi therapies can get deep into brain tissue, yielding new ways to treat ...

Senators challenged Kennedy, who was nominated as health secretary by President Trump, on his long track record of ...

The expansion is a natural progression for Upperton who already develops and manufactures small molecule and biological, ...

In an interview, the CEO discussed trying to gain support from investors hyper-focused on M&A, and competing with Pfizer and ...